Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
CAN CSA C22.2 No. 80601-2-58-15: Essential Engineering Guide to Ophthalmic Surgical Equipment Safety
Understanding the Technical Requirements, Scope, and Compliance Path for Lens Removal and Vitrectomy Devices in Canada
CAN CSA C22.2 No. 80601-2-58-15 is a Canadian national standard that adopts the international IEC 80601-2-58 with specific modifications for the Canadian context. It provides particular requirements for the basic safety and essential performance of lens removal devices and vitrectomy devices used in ophthalmic surgery. These devices employ vibration, aspiration, and infusion to fragment and remove lens material or vitreous humor. This article details the scope, technical obligations, and compliance procedures associated with this standard.
1. Scope and Application
The standard applies to medical electrical equipment intended for use in ophthalmology to perform lens removal (phacofragmentation) and vitrectomy (vitreous body removal). The devices typically include:
- Handpieces with cutting or ultrasonic mechanisms
- Fluid management consoles with aspiration and infusion pumps
- Foot controllers and associated control electronics
- Accessories such as tubing, cassette sets, and probes that are essential for normal use
The equipment may be mains-powered (AC) or battery-powered (DC). Devices that rely exclusively on laser energy or standalone ultrasonic phacoemulsification are explicitly excluded from this standard; those modalities are covered by other particular standards (e.g., IEC 80601-2-60 for phacoemulsification). The standard does not apply to implantable parts or devices intended for veterinary use.
Tip: Manufacturers should determine early if their device qualifies as a lens removal or vitrectomy device per the definitions in Clause 201.3.201 of the standard. Combining multiple functions (e.g., both lens removal and vitrectomy in one console) requires application of the most stringent requirements for each function.
2. Technical and Safety Requirements
CAN CSA C22.2 No. 80601-2-58-15 builds upon the general safety standard CAN/CSA-C22.2 No. 60601-1 (third edition) and adds specific requirements for ophthalmic surgical equipment. Key technical areas include:
2.1 Electrical and Mechanical Safety
Equipment must comply with the general ME requirements for leakage currents, dielectric strength, and protection against electrical shock (Types B, BF, CF applied parts). Mechanical hazards such as moving parts, unexpected ejection of probes, and stability must be addressed. Any fluidics system must prevent excessive pressure that could cause ocular trauma; the standard mandates maximum pressure limits and redundant shut-off mechanisms.
2.2 Essential Performance
The standard defines essential performance parameters that must be maintained under both normal and single-fault conditions. These include:
| Parameter | Requirement |
|---|---|
| Aspiration flow rate accuracy | ±15 % of the setpoint value |
| Maximum vacuum (negative pressure) | Shall not exceed 600 mmHg or manufacturer’s declared limit, whichever is lower |
| Infusion pressure accuracy | ±10 % of the setpoint |
| Occlusion detection and response | Alarm and pump stop within 2 s of a full occlusion |
| Cut rate (vitrectomy probes) | Accuracy within ±5 % of the displayed rate over all operating conditions |
| Alarm prioritization | High-priority alarms for pressure limit violations, occlusion, and system faults |
2.3 Usability and Human Factors
The standard requires that controls, displays, and alarms be understandable and intuitive for the surgical team. The device must be designed to minimize the risk of unintended operation, especially during critical phases of the procedure. Labeling and instructions for use (IFU) must include warnings about hazards such as infusion air embolism, excessive vacuum, and cross‑contamination.
Warning: Inadequate usability testing has been a common source of non‑compliance. The standard explicitly references IEC 62366-1:2015 (medical device usability) and expects manufacturers to demonstrate that use‑related risks have been reduced to an acceptable level.
3. Implementation Considerations for Manufacturers
Adhering to CAN CSA C22.2 No. 80601-2-58-15 requires a systematic engineering approach. The following points are critical during design and development:
- Risk management: Establish a risk management file per ISO 14971, with special attention to fluidics hazards, occlusion detection failure, and electrical safety under wet conditions (presence of saline).
- Software validation: If the device incorporates programmable electronic systems (PESS), software lifecycle activities must comply with IEC 62304. This includes classification of the software (Class B or C depending on function) and conducting appropriate verification and validation.
- Clinical evaluation: The standard expects that the device’s essential performance is verified through bench tests and, when appropriate, clinical evidence.
- Labeling and marking: Equipment must bear the CSA mark (or other accepted certification mark) and include model/serial number, electrical ratings, and safety symbols per CAN/CSA C22.2 No. 60601-1.
Compliance tip: Using a pre‑established test protocol that follows the Annex A (normative) test sequences of the standard can streamline the evaluation. Many accredited laboratories offer tailored testing packages for this specific standard.
4. Compliance and Certification in Canada
To place a lens removal or vitrectomy device on the Canadian market, manufacturers must:
- Apply for a Medical Device License (MDL) with Health Canada or follow the establishment licensing route for class II devices. This standard is typically applied to Class III or Class IV devices depending on the claims made.
- Submit evidence of conformity with CAN CSA C22.2 No. 80601-2-58-15 as part of the technical documentation required by SOR/98-282 (Canadian Medical Devices Regulations).
- Engage a certification body accredited by SCC (e.g., CSA Group, UL, QPS) to perform independent testing and issue a certification report.
- Maintain a quality management system certified to ISO 13485 or equivalent.
The standard includes several Canadian deviations from the base IEC 80601-2-58, notably in the areas of electrical supply voltage ratings (nominal 120 V / 60 Hz) and bilingual labeling requirements (English and French). Manufacturers must ensure that the technical documentation reflects these modifications.
Non‑compliance risk: Failure to adhere to the standard’s requirements may result in regulatory action by Health Canada, including suspension of the MDL, mandatory recall, or prohibition of sale. Always confirm with the certification body before finalizing the design.
Frequently Asked Questions
Q: What is the difference between CAN CSA C22.2 No. 80601-2-58-15 and IEC 80601-2-58?
A: The CSA edition adopts the technical content of the IEC 80601-2-58 (which was published in 2014) with Canadian national differences. Differences include voltage ranges (120 V / 60 Hz instead of 220‑240 V / 50 Hz), bilingual labeling requirements, and references to Canadian electrical safety codes (C22.2 series). CSA also provides guidance on the relationship with the Canadian Medical Devices Regulations.
A: The CSA edition adopts the technical content of the IEC 80601-2-58 (which was published in 2014) with Canadian national differences. Differences include voltage ranges (120 V / 60 Hz instead of 220‑240 V / 50 Hz), bilingual labeling requirements, and references to Canadian electrical safety codes (C22.2 series). CSA also provides guidance on the relationship with the Canadian Medical Devices Regulations.
Q: Does this standard cover phacoemulsification devices used for cataract surgery?
A: No, phacoemulsification devices that use ultrasonic energy to emulsify the lens are covered by CAN/CSA C22.2 No. 80601-2-60 (adopting IEC 80601-2-60). The 80601-2-58 standard addresses devices that fragment lens material through vibration, cutting, or fluid-based methods other than continuous ultrasonic phaco. Devices combining both technologies must comply with both standards.
A: No, phacoemulsification devices that use ultrasonic energy to emulsify the lens are covered by CAN/CSA C22.2 No. 80601-2-60 (adopting IEC 80601-2-60). The 80601-2-58 standard addresses devices that fragment lens material through vibration, cutting, or fluid-based methods other than continuous ultrasonic phaco. Devices combining both technologies must comply with both standards.
Q: Are there special requirements for battery‑powered devices?
A: Yes. Battery‑operated lens removal or vitrectomy devices must additionally comply with the rechargeable battery requirements of IEC 60601-1 (Clause 15.4). The standard also requires that the device function safely under low‑battery conditions, providing a clear indication before shutdown and preventing any sudden loss of essential performance.
A: Yes. Battery‑operated lens removal or vitrectomy devices must additionally comply with the rechargeable battery requirements of IEC 60601-1 (Clause 15.4). The standard also requires that the device function safely under low‑battery conditions, providing a clear indication before shutdown and preventing any sudden loss of essential performance.
Q: How often is the standard updated?
A: CSA typically aligns with the IEC revision cycle. The current edition is based on IEC 80601-2-58:2014 + AMD1:2016. CSA may issue amendments or adopt newer editions when published. Manufacturers should monitor the IEC and CSA websites for the latest updates.
A: CSA typically aligns with the IEC revision cycle. The current edition is based on IEC 80601-2-58:2014 + AMD1:2016. CSA may issue amendments or adopt newer editions when published. Manufacturers should monitor the IEC and CSA websites for the latest updates.
© 2026 Canadian Standards Association. This article provides general technical information; always refer to the official published standard for complete requirements.